Escin
PreclinicalSmall molecule
Escin is one of 3 small molecule programs targeting Third Molar Surgery. It is currently in Preclinical.
1
Indications
3
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Third Molar Surgery
#DrugCompanyPhaseTrials
1Antibiotic
PfizerPhase 1
Concentrated PRF
IInonu University
Preclinical
Escin
OOman Medical Speciality Board
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Escin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- OOman Medical Speciality Board